Determination of pyridonecarboxylic acids in plasma by reverse-phase high-performance liquid chromatography.
A simple qualitative and quantitative determination for pyridonecarboxylic acids including nalidixic acid (NA), oxolinic acid (OA) and pipemidic acid (PPA) in chicken plasma was carried out by microbiological, spectrophotometric, thin-layer chromatographic (TLC) and reverse-phase high-performance liquid chromatographic (HPLC) methods. As a test organism for bacteriological bioassay, Bacillus subtilis ATCC-6633 was the most sensitive of seven organisms investigated. Using the cup and the disc methods, a standard curve was obtained by determining the relationship between various drug concentrations and the diameter of the inhibition zone. The three drugs had two strong UV absorbance wavelengths (257 and 330 nm) on spectrophotometry. TLC analysis using a silica gel 60 F254 plate was investigated, and a solution of methanol:chloroform:acetic acid (3:1:1, v/v/v) was found to be the most suitable solvent for separation. The minimum concentration of drug detectable by this method was 0.5 microgram/ml for NA, 0.075 microgram/ml for OA and 0.39 microgram/ml for PPA. For HPLC analysis, a solution of acetonitrile:0.2 M phosphoric acid (1:1, v/v) was superior, and simultaneous determination of all three drugs was possible under the HPLC conditions used. The lowest measurable amount of drug in chicken plasma was 0.01 microgram/g. Recovery from extracts spiked with each drug at a known concentration was close to 100% for NA and OA, but only about 50% for PPA.
Kondo
F
F
Department of Veterinary Public Health, Faculty of Agriculture, Miyazaki University, Japan.
Nagata
S
S
Tsai
C E
CE
Saitanu
K
K
D000818:Animals; D000892:Anti-Infective Agents, Urinary / Q000097:blood*; D001681:Biological Assay; D002264:Carboxylic Acids / Q000097:blood*; D002645:Chickens / Q000097:blood*; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D004350:Drug Residues / Q000032:analysis*; D004926:Escherichia coli / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000097:blood / Q000494:pharmacology; D010093:Oxolinic Acid / Q000097:blood / Q000494:pharmacology; D010876:Pipemidic Acid / Q000097:blood / Q000494:pharmacology; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet
D000892:Anti-Infective Agents, Urinary; D002264:Carboxylic Acids; D009268:Nalidixic Acid; D010093:Oxolinic Acid; D010876:Pipemidic Acid